top of page

Continuous Glucose Monitoring

Transforming Non-Invasive Medical Diagnostics

Know Labs' proprietary non-invasive diagnostic technology platform uses radio waves to identify and measure a wide range of organic and inorganic materials, molecules, and compositions of matter.

Form Factor Agnostic

A technology platform that can be integrated into a variety of wearable, mobile or bench-top form factors.

100+ Diagnostic Applications

Has the potential to identify and measure different molecules in and out of the the body, such as glucose, oxygen, alcohol, metabolized drugs, and further industrial applications.

Pain- & Waste-Free

No needles nor invasive transmitters in your body. Expensive supplies, such as test strips and lancets, are not required. 


3x-5x less expensive than current blood glucose monitoring options on the market. 

Desk Laptop

“The holy grail of the medical industry and patient care.”

James H Anderson Jr., MD, FFPM, FACE
Chief Medical Officer, Know Labs
Former Senior Medical Director, Diabetes and CardioMetabolic Medicine, Eli Lilly and Company


Know Labs is developing products that can non-invasively identify and measure molecules in and out of the body.

The KnowU is a non-invasive, wearable continuous blood glucose monitor designed to improve how 2 billion people with diabetes and pre-diabetes manage their conditions.

Ipad screen viewing Know Labs video

Continuous Wearable


The KnowU can be worn with an adhesive, so you can clip the sensor on and off, or on the wrist or forearm with a strap.

The KnowU will last for years, eliminate costly disposables, have a rechargeable battery, and connect with an easy-to-use companion mobile app. 

GlucoseDashboard mobile application

Mobile Companion App

Check your blood glucose level in real-time, and your trends over time.


The Know Labs Difference

Global Innovator

Novel approach to blood glucose monitoring using RF dielectric spectroscopy. 

Medical Device

Medical-grade device with high level of accuracy, on the path to FDA clinical trials for clearance.

IP Leadership

270+ patents issued, pending, and in-process worldwide, covering 100+ applications and creating a defensible moat surrounding its technology.


Highly accurate, non-invasive solution does not require costly disposables and that is economical for both patients and society.


Recent Updates

June 21, 2024

Know Labs to Present at the American Diabetes Association’s Scientific Sessions

June 5, 2024

Know Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University.

bottom of page